177 related articles for article (PubMed ID: 26168763)
21. Advocacy for harm reduction in China: a new era dawns.
Reid G; Aitken C
Int J Drug Policy; 2009 Jul; 20(4):365-70. PubMed ID: 19097773
[TBL] [Abstract][Full Text] [Related]
22. If supply-oriented drug policy is broken, can harm reduction help fix it? Melding disciplines and methods to advance international drug-control policy.
Greenfield VA; Paoli L
Int J Drug Policy; 2012 Jan; 23(1):6-15. PubMed ID: 21689918
[TBL] [Abstract][Full Text] [Related]
23. A review of drug policy in the Golden Crescent: towards the development of more effective solutions.
Talpur A; George TP
Asian J Psychiatr; 2014 Dec; 12():31-5. PubMed ID: 25440559
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of Iranian women seeking drug treatment.
Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A
J Womens Health (Larchmt); 2011 Nov; 20(11):1687-91. PubMed ID: 21905877
[TBL] [Abstract][Full Text] [Related]
25. Reducing the harm of "harm reduction".
Beirness DJ; Notarandrea R; Jesseman R; Perron M
Clin Pharmacol Ther; 2008 Apr; 83(4):523-5. PubMed ID: 18349874
[TBL] [Abstract][Full Text] [Related]
26. Methadone maintenance therapy outcomes in Iran.
Noori R; Narenjiha H; Aghabakhshi H; Habibi G; Khoshkrood Mansoori B
Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
[TBL] [Abstract][Full Text] [Related]
27. The Effectiveness of Harm Reduction Programs in Seven Prisons of Iran.
Roshanfekr P; Farnia M; Dejman M
Iran J Public Health; 2013 Dec; 42(12):1430-7. PubMed ID: 26060645
[TBL] [Abstract][Full Text] [Related]
28. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
Ritter A; Cameron J
Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
[TBL] [Abstract][Full Text] [Related]
29. The role of community-based nurses in harm reduction for HIV prevention: a South East and South Asia case study.
Limbu B
Int J Drug Policy; 2008 Jun; 19(3):211-3. PubMed ID: 18440796
[TBL] [Abstract][Full Text] [Related]
30. HIV infection among female drug users in Northern Thailand.
Srirak N; Kawichai S; Vongchak T; Razak MH; Jittiwuttikarn J; Tovanabutra S; Rungruengthanakit K; Keawvichit R; Beyrer C; Wiboonatakul K; Sripaipan T; Suriyanon V; Celentano DD
Drug Alcohol Depend; 2005 May; 78(2):141-5. PubMed ID: 15845317
[TBL] [Abstract][Full Text] [Related]
31. Ups and downs of addiction harm reduction in Iran: key insights and implications for harm reduction policy and policing.
Shafiee SA; Vedadhir A; Razaghi E
Harm Reduct J; 2023 Jan; 20(1):8. PubMed ID: 36670386
[TBL] [Abstract][Full Text] [Related]
32. Harm Reduction: Front Line Public Health.
Stancliff S; Phillips BW; Maghsoudi N; Joseph H
J Addict Dis; 2015; 34(2-3):206-19. PubMed ID: 26080038
[TBL] [Abstract][Full Text] [Related]
33. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
Gidman W; Coomber R
Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
[TBL] [Abstract][Full Text] [Related]
34. Drug abuse in Asia.
Suwanwela C; Poshyachinda V
Bull Narc; 1986; 38(1-2):41-53. PubMed ID: 3535959
[TBL] [Abstract][Full Text] [Related]
35. Tracing a path for opium gum from Mexico as a safe supply harm reduction measure for Canada.
Snapp Z; Valderrábano JH
Int J Drug Policy; 2021 May; 91():103066. PubMed ID: 33549465
[TBL] [Abstract][Full Text] [Related]
36. Assembling the dominant accounts of youth drug use in Australian harm reduction drug education.
Farrugia A
Int J Drug Policy; 2014 Jul; 25(4):663-72. PubMed ID: 24882707
[TBL] [Abstract][Full Text] [Related]
37. Improving health and social care relationships for harm reduction.
Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
[TBL] [Abstract][Full Text] [Related]
38. HIV Programs in Iran (Persia), Iraq and Saudi Arabia: A Brief Review of Current Evidence in West and Southwest Asia.
Massah O; Moradi A; Farhoudian A; Amini-Lari M; Joulaei H; Daneshmand R
Addict Health; 2016 Jul; 8(3):136-144. PubMed ID: 28496952
[TBL] [Abstract][Full Text] [Related]
39. Post-Soviet Central Asia: a summary of the drug situation.
Zabransky T; Mravcik V; Talu A; Jasaitis E
Int J Drug Policy; 2014 Nov; 25(6):1186-94. PubMed ID: 24954816
[TBL] [Abstract][Full Text] [Related]
40. Update on harm-reduction policy and intervention research.
Marlatt GA; Witkiewitz K
Annu Rev Clin Psychol; 2010; 6():591-606. PubMed ID: 20192791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
